Fifteen students will participate in the Eco-educational Camp "With the Smell of Resin" for children from poor families in the Rakitovo region. The camp will be accomplished by a team of the Baikaria Association. Since the interest in this camp is great, children will be selected not by social principle alone (brought up by relatives or by a single parent, or in a family of unemployed). Candidates will write an essay on an environmental topic, and the competition has been organised with the assistance of the school in Rakitovo.

The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that from 16. August 2012 up to and including 22. August 2012 the Company bought 11650 own shares representing 0.0088% of the share capital of the Company, at a total value of BGN 28325.60 on the Bulgarian Stock Exchange. The average price per share was BGN 2.431.

The shares have been bought on the basis of the general meeting resolution of 23. June 2010.

Sopharma AD (the “Company”) notifies that for September 2014 the Company recorded an increase of sales revenues of 3% compared to the same month of 2013, including 6% increase of domestic sales and 2% increase of export sales. During the past nine months Sopharma AD recorded a decrease of sales revenues of 5%, including 3% increase of domestic sales and 8% decrease of export sales compared to the same period of 2013.

SOPHARMA AD hereby informs that from 2 October 2014 up to and including 8 October 2014 the Company bought 14 015 own shares representing 0.011% of the share capital of the Company, to the total value of 56 025.88 BGN on the Bulgarian Stock Exchange, the average price per share was 3.998 BGN. The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010. The total number of treasury shares after these transactions is 5 101 113, representing 3.86% of the share capital of the Company.

SOPHARMA AD hereby informs that from 9 October 2014 up to and including 15 October 2014 the Company bought 1 745 own shares representing 0.0013% of the share capital of the Company, to the total value of 6 955.83 BGN on the Bulgarian Stock Exchange, the average price per share was 3.99 BGN. The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010. The total number of treasury shares after these transactions is 5 102 858, representing 3.87% of the share capital of the Company.

SOPHARMA AD hereby informs that from 16 October 2014 up to and including 22 October 2014 the Company bought 1 819 own shares representing 0.0014% of the share capital of the Company, to the total value of 7 188.11 BGN on the Bulgarian Stock Exchange, the average price per share was 3.95 BGN. The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010. The total number of treasury shares after these transactions is 5 104 677, representing 3.87% of the share capital of the Company.

SOPHARMA AD hereby informs that from 23 October 2014 up to and including 29 October 2014 the Company bought 1 375 own shares representing 0.001% of the share capital of the Company, to the total value of 5389.9 BGN on the Bulgarian Stock Exchange, the average price per share was 3.92 BGN. The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010. The total number of treasury shares after these transactions is 5 106 052, representing 3.87% of the share capital of the Company.

Sopharma AD (the “Company”) announces that on 3 November 2014 the Company bought 500 000 shares from the capital of Medika AD. After this transaction, the share of Sopharma AD in the capital of Medika AD increased to 19, 22%.

Sopharma AD (the “Company”) announces that on 4 November 2014 the Company bought 400 010 shares from the capital of Medika AD. After this transaction, the share of Sopharma AD in the capital of Medika AD increased to 23.20%.

Sopharma AD (the “Company”) notifies that for October 2014 the Company recorded an increase of sales revenues of 4% compared to the same month of 2013, including 12% increase of domestic sales and 1% increase of export sales. During the past ten months Sopharma AD recorded a decrease of sales revenues of 4%, including 4% increase of domestic sales and 7% decrease of export sales compared to the same period of 2013